Phase 1 biotech developing small molecule therapies for treatment-resistant cancers.
Industry: Health Care
First Day Return: +61.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/28/2020 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/23/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2014 |
Employees at IPO | 57 |
Website www.oricpharma.com |